Arixtra is indicated for the prophylaxis of deep vein thrombosis.
Mylan will pay $225 million to acquire the rights for commercialization, marketing and intellectual property. Another $75 million is contingent upon satisfaction of certain conditions.
More articles on acquisitions:
3 recent hospital transactions and partnerships
J&J seeks buyer for medical device business
Covidien acquires medical device firm Sapheon
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
